Table 3.
Functional outcomes and SICH by the TyG index on continuous scale (per unit).
| Models | N | Events (%) | Age, sex- adjusted of TyG index | Multivariable- adjusted† of TyG index | ||
|---|---|---|---|---|---|---|
| Variable | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
| Unfavorable functional outcomes at 90 days | 813 | 68.4% (556/813) | 1.27 (1.02–1.58) | 0.0361* | 1.32 (1.01–1.73) | 0.0431* |
| Mortality at 90 days | 813 | 8.5% (69/813) | 1.09 (0.76–1.56) | 0.6573 | 1.16 (0.76–1.76) | 0.4959 |
| SICH at 24–36 h by NINDS | 914 | 5.1% (47/914) | 0.83 (0.53–1.30) | 0.4217 | 1.00 (0.62–1.62) | 0.9947 |
| SICH at 24–36 h by ECASS II | 914 | 2.8% (26/914) | 1.24 (0.70–2.19) | 0.4698 | 1.22 (0.67–2.21) | 0.5255 |
| SICH at 24–36 h by SITS-MOST | 914 | 1.3% (12/914) | 1.43 (0.62–3.29) | 0.4065 | 1.27 (0.51–3.16) | 0.6133 |
NINDS, National Institute of Neurological Disorders and Stroke; OR, odds ratio; SITS-MOST, Safe Implementation of Thrombolysis in Stroke-Monitoring Study; UFO, unfavorable functional outcome.
Statistically significant at p < 0.05.
The multivariate logistic regression analysis was adjusted for age, sex, hypertension, and atrial fibrillation.